Brief: Acurx Pharmaceuticals Reports Fourth Quarter Results
16/03/2023 11:03
March 16 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS FOURTH QUARTER AND
FULL YEAR
2022 RESULTS AND PROVIDES BUSINESS UPDATE
* ACURX PHARMACEUTICALS INC - ENDED YEAR, WITH CASH TOTALING
$9.1
MILLION COMPARED TO $13.0 MILLION AS OF DECEMBER 31, 2021
* ACURX PHARMACEUTICALS INC - NET LOSS OF $3.3 MILLION OR
$0.28
PER DILUTED SHARE FOR THREE MONTHS ENDED DECEMBER 31, 2022
Source text for Eikon: ID:nPn6BrJlNa
Further company coverage: ACXP.O
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln